Nutritional approaches in combating therapeutic resistance and enhancing treatment efficacy in cancer: the impact of ketogenic diets
Authors:
Open Access
- 15 December 2025
- journal article
- review article
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 23 (1)
Abstract
Cancer remains a major global health challenge, with therapeutic resistance significantly limiting treatment success. Traditional approaches, including surgery, chemotherapy, and radiotherapy, often encounter barriers such as metastasis and adverse effects on healthy tissues. The Warburg effect, which describes cancer cells’ reliance on glucose fermentation despite oxygen availability, has prompted investigations into alternative metabolic interventions. The ketogenic diet (KD), characterized by high fat intake and low carbohydrate intake, induces a metabolic shift that may selectively disadvantage malignant cells while preserving normal tissue function. While emerging evidence, including preclinical studies, early-phase trials, and limited clinical series, suggests that KD may help overcome treatment resistance by suppressing the PI3K/Akt/mTOR pathway, reducing insulin-like growth factor-1 (IGF-1) signaling, and enhancing cancer cell susceptibility to chemotherapy and targeted therapies, robust data from large, randomized controlled trials (RCTs) remain sparse. Most current findings derive primarily from animal models and small pilot studies, with definitive efficacy and safety in broad patient populations yet to be established. Preclinical and preliminary clinical studies indicate KD’s potential in modulating epigenetic markers, reducing inflammation, and improving patient metabolic health. However, patient adherence remains challenging and standardized protocols are still under development. This review explores the molecular mechanisms underlying KD’s anticancer effects, its role in mitigating drug resistance, and current translational insights, with emphasis on the nascent stage of high-quality clinical trial evidence and areas for future research.Keywords
This publication has 153 references indexed in Scilit:
- Ketotherapy as an epigenetic modifier in cancerReviews in Endocrine and Metabolic Disorders, 2020
- The Therapeutic Ketogenic Diet: Harnessing Glucose, Insulin, and Ketone Metabolism2020
- Glutamine Metabolism in Cancer2018
- HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)Tumor Biology, 2015
- Investigating a signature of temozolomide resistance in GBM cell lines using metabolomicsJournal of Neuro-Oncology, 2015
- High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancerInternational Journal of Cancer, 2013
- Calorie Restriction and Cancer Prevention: Established and Emerging Mechanisms2013
- Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cellsMetabolomics, 2013
- Leucine nutrition in animals and humans: mTOR signaling and beyondAmino Acids, 2011
- Metabolic assessment of a novel chronic myelogenous leukemic cell line and an imatinib resistant subline by 1H NMR spectroscopyMetabolomics, 2010